Skip to main content

PDK Laboratories Inc. v. United States Drug Enforcement Administration

D.C. CircuitFebruary 24, 2006No. 04-1432Cited 22 times
Defendant WinUnited States Drug Enforcement Administration

Case Details

Judge(s)
Tatel, Garland, Edwards
Status
Published
Procedural Posture
appeal
Circuit
DC Circuit

Related Laws

No specific laws identified for this ruling.

Outcome

The court upheld DEA's suspension orders, rejecting PDK Laboratories' challenge. The court affirmed that DEA reasonably interpreted 'listed chemical' to include ephedrine and pseudoephedrine in finished drug products, and that substantial evidence supported the suspension orders.

Similar Rulings

American Association of Physicians for Human Rights, Inc. v. National Institutes of Health
D. Md.Aug 2025
Defendant Win
Maluf
D. Nev.Aug 2024
Defendant Win
Adams
D.D.C.May 2014
Unresolvable
Center for Biological Diversity v. Lee Zeldin
D.C. CircuitMar 2026
DOJ
D.C. CircuitMar 2026
Unresolvable
Read Full OpinionMore United States Drug Enforcement Administration RulingsAll Rulings

Facing something similar at work?

Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.

Check Your RightsLearn the Basics

This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.